| Returns | 1W : -1.4% , 1M : -10.7%,1Y : 62.6% | www.venkys.com |
| LT : |
Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued] Debt : Low |
| ST : |
Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
| Peers & Returns | 1W | 1M | 1Y |
| VENKYS (INDIA) | -1.4% | -10.7% | 62.6% |
| BOMBAY BURMAH TRADING CORPORATION | -3.5% | -5.1% | -16.3% |
| KAVERI SEED COMPANY | 1.6% | -3.6% | 2.4% |
| NATH BIOGENES (INDIA) | -2.3% | -12% | 1.7% |
| HARRISONS MALAYALAM | 3.7% | -6.4% | 57.4% |
| JK AGRI GENETICS | 1.8% | -1.7% | 12.1% |
| BOMBAY SUPER HYBRID SEEDS | -0.5% | -4.9% | 190.6% |
| SHREE GANESH BIOTECH (INDIA) | 0.3% | -0.4% | 35.3% |
| MANGALAM GLOBAL ENTERPRISE | 2.2% | 29.8% | 148.6% |
| Ratio | Standalone |
|---|---|
|
P/E P/B P/S |
13.24
P/E Calculated based on EPS of 190.05
[ Mar2021 - Standalone Results ] 3.21
P/B Calculated based on Book Value of 783.98
[ Mar2021 - Standalone Results ] 0.9
P/S Calculated based on Revenues of 3945.47 Cr
[ TTM - Standalone Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
-6% 12% 25% |
| Pledged Shares |
0 % |
|---|---|
| As on : Sep2021 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE SMALL CAP | 0.5% | -1.3% | 79.5% |
| S&P BSE 250 SMALLCAP | -0.1% | -2.1% | 79.1% |
| S&P BSE MIDSMALLCAP | -0.5% | -2.1% | 68.4% |
| S&P BSE 400 MIDSMALLCAP | -0.8% | -2.6% | 67.4% |
| S&P BSE ALLCAP | -1.7% | -5.1% | 44.6% |
| S&P BSE 500 | -1.9% | -5.3% | 43.3% |
| S&P BSE FMCG | -1.9% | -3.8% | 22.7% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY SMALLCAP250 | 0.3% | -1.2% | 83.1% |
| NIFTY MID SMALL400 | -0.8% | -2.3% | 68.1% |
| NIFTY500 MULTICAP 50:25:25 | -1.3% | -4% | NA |
| NIFTY 500 | -1.8% | -5.1% | 43.1% |
|
Quarterly Results of BOMBAY BURMAH TRADING CORPORATION LTD Quarterly Results of KAVERI SEED COMPANY LTD Quarterly Results of NATH BIOGENES (INDIA) LTD Quarterly Results of HARRISONS MALAYALAM LTD |
#15A, 4th Floor, City Vista, Tower A,
Suite No.984, Fountain Road,
Kharadi, Pune - 411014
Contact Us
support@smart-investing.in
Smart-Investing.in
Pricing
Video Course
Blog
Tools
Screener
Compare
Analyze Portfolio
© 2019 - 2021 Smart-Investing.in. All rights reserved. Built with ❤️ in India
Disclaimer
The information on this site is for educational purposes only and is not investment/trading advice/research and may be delayed.
We don't make any Buy/Sell recommendations and don't give any price targets.
This tool provides statistical summaries of financial data in easy to understand visual form for informational purpose only.
Please do your own research before making any investment decisions.
Equity investments are volatile and high risk in nature. Don't invest more than what you can afford to lose. Past Performance is not indicative of future returns.
We have affiliate relationships with Amazon and Zerodha.
Financial Data Source: Accord Fintech |
Methodology |
Privacy Policy |
Terms & Conditions |
SEBI Registered Research Analyst Registration No : INH000007377 |
Disclosure